Assessing Copy Number Alterations in Targeted, Amplicon-Based Next-Generation Sequencing Data
- 7 November 2014
- journal article
- Published by Elsevier BV in The Journal of Molecular Diagnostics
- Vol. 17 (1), 53-63
- https://doi.org/10.1016/j.jmoldx.2014.09.008
Abstract
No abstract availableKeywords
Funding Information
- Knight Cancer Institute
- Department of Pathology, Oregon Health and Science University research
This publication has 21 references indexed in Scilit:
- The estimation of tumor cell percentage for molecular testing by pathologists is not accurateLaboratory Investigation, 2014
- Detecting Somatic Genetic Alterations in Tumor Specimens by Exon Capture and Massively Parallel SequencingJournal of Visualized Experiments, 2013
- Accurate Detection of Copy Number Changes in DNA Extracted from Formalin-Fixed, Paraffin-Embedded Melanoma Tissue Using Duplex Ratio TestsThe Journal of Molecular Diagnostics, 2013
- Molecular Diagnostic Profiling of Lung Cancer Specimens with a Semiconductor-Based Massive Parallel Sequencing ApproachThe Journal of Molecular Diagnostics, 2013
- Combining Highly Multiplexed PCR with Semiconductor-Based Sequencing for Rapid Cancer GenotypingThe Journal of Molecular Diagnostics, 2013
- Targeted polymerase chain reaction-based enrichment and next generation sequencing for diagnostic testing of congenital disorders of glycosylationGenetics in Medicine, 2011
- Targeted high throughput sequencing in clinical cancer Settings: formaldehyde fixed-paraffin embedded (FFPE) tumor tissues, input amount and tumor heterogeneityBMC Medical Genomics, 2011
- Integrated detection and population-genetic analysis of SNPs and copy number variationNature Genetics, 2008
- Segmental Duplications and Copy-Number Variation in the Human GenomeAmerican Journal of Human Genetics, 2005
- High resolution analysis of DNA copy number variation using comparative genomic hybridization to microarraysNature Genetics, 1998